Cell Ready, LLC entered into a purchase agreement to acquire Certain Cell Manufacturing Assets of Marker Therapeutics, Inc. for $19 million on May 1, 2023. Transaction is expected to close on June 26, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 USD | +10.66% | +5.50% | -30.18% |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
05-15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.18% | 30.95M | |
+50.51% | 56.95B | |
+39.98% | 40.26B | |
-6.97% | 39.32B | |
-4.42% | 28.37B | |
+11.97% | 26.45B | |
-18.23% | 19.41B | |
+30.17% | 12.54B | |
+25.35% | 12.21B | |
-0.12% | 12.15B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Cell Ready, LLC entered into a purchase agreement to acquire Certain Cell Manufacturing Assets of Marker Therapeutics, Inc. for $19 million.